Thermometer Market To Benefit from Increased Global Uptake of 2021 By 2028

 Thermometer Market Growth & Trends

The global thermometer market size is expected to reach USD 2.34 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% from 2021 to 2028. An increase in the demand for accurate medical devices and the requirement of specific temperature conditions influence the market growth.

The rising cases of medical ailments involving accurate measurement of body temperature for the treatment planning and requirement of specific temperature conditions in various industries are likely to heighten the demand for thermometers during the forecast period. The rise in health consciousness, coupled with an increase in healthcare expenditure, is also anticipated to fuel market growth further in the coming decade.

The increasing prevalence of target diseases, such as malaria, dengue, typhoid, and swine flu, which cause fever, is anticipated to be a high-impact rendering driver of the market. Malaria is one of the most fatal diseases and is one of the leading causes of death globally. According to the World Malaria Report 2019, an estimated 229 million cases of malaria were observed in 2019 globally.

Furthermore, rapid technological advancements in temperature monitoring devices are increasing the acceptance of these devices by people. For instance, in 2018, Optics developed upgrades for its compact infrared thermometers, which improved their speed and flexibility for industrial use. This is expected to boost the market growth during the forecast period.

Request a free sample copy or view report summary: Thermometer Market Report

Thermometer Market Report Highlights

• Based on product, mercury-free thermometers dominated the market with a share of 62.52% in 2020 and are expected to witness significant growth from 2021 to 2028. This can be attributed to the high adoption owing to cost-effectiveness, higher efficacy, and beep indication on temperature fluctuations
• On the basis of application, the medical segment dominated the market with a share of 28.53% in 2020 owing to the high prevalence of diseases, which require body temperature assessment for the treatment planning
• North America dominated the market with a revenue share of 34.45% in 2020 owing to the increasing incidences of infectious diseases, such as COVID-19 and Influenza, and the presence of well-established healthcare facilities in this region

Access Press Release of Thermometer Market @ https://www.grandviewresearch.com/press-release/global-thermometer-market

Thermometer Market Segmentation

Grand View Research has segmented the global thermometer market on the basis of product, application, and region:

Thermometer Product Outlook (Revenue, USD Million, 2016 - 2028)

• Mercury-based Thermometers
• Mercury-free Thermometers
  • Infrared Radiation Thermometers
  • Digital Thermometers
  • Others

Thermometer Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
• Industrial
• Food
• Laboratory
• Others

Thermometer Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa (MEA)
  • South Africa

List of Key Players of Thermometer Market

• Medline Industries, Inc.
• 3M
• Welch Allyn
• American Diagnostics Corporation
• A&D Medical
• Exergen Corporation
• Microlife Corporation
• RG Medical Diagnostics
• Medtronic
• Terumo Corporation
• Actherm Inc.
• Briggs Healthcare
• OMRON Healthcare Inc.
• Fairhaven Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Gene Therapy Market is projected to grow moderately at 20.4% CAGR through 2028: Grand View Research Inc.

 

Gene Therapy Market Growth & Trends

The global gene therapy market size is expected to reach USD 10.0 billion by 2028 registering a CAGR of 20.4% during the forecast period, according to a new report by Grand View Research, Inc. The market growth is attributed to the increasing prevalence of cancer coupled with the lack of effective treatment for the disease. Constant expansion of cancer genetic studies has deciphered relevant information about cancer-related molecular signatures.

This has driven the clinical trials for advanced cancer therapeutics, thereby driving the market growth. In addition, expansion of this mode of treatment in non-cancer applications with approval of therapies, such as approval of Bluebird Bio’s Zynteglo in June 2019 for β-thalassemia and others, demonstrates the shift in the preferences of companies towards other unsaturated segments.

Various universities and institutes are observed to exhibit a broad portfolio in the pipeline, which is anticipated to boost revenue generation in the future. The market is anticipated to witnesses a short-term revenue slowdown due to a shift in focus and delay in product launches. However, initiatives for developing novel trial designs, improving the regulatory environment, and managing the supply chain are expected to play a critical role in minimizing the impact of the current global crisis.

Request a free sample copy or view report summary: Gene Therapy Market Report

Gene Therapy Market Report Highlights

• Viral vectors have proven their efficiency as a method for effective gene deliveries. As a result, a substantial number of research communities and biotechnology companies have designed their gene therapy programs based on viral vectors
• Moreover, most of currently FDA-secured products involve the use of viral vectors, which contributes to the dominance of the viral vectors segment
• Due to the approval and huge success of lentivirus-based Kymriah and retrovirus-based Yescarta, retrovirus and lentivirus are also among the key revenue-generating segments
• Cancer has led the revenue flow in the market over the past few years and is expected to maintain its dominance in the forecast period
• The presence of approved products for various cancer forms including Large B-cell lymphoma, Acute Lymphoblastic Leukemia (ALL), and melanoma has resulted in the dominance of this segment
• The U.S. is recognized as the hub for clinical trials related to gene therapy. This has significantly impacted the revenue growth of the North America market
• Also, the success of Yescarta and Kymriah in the U.S. as the first approved CAR-t therapy programs has driven huge investments by various government agencies, sponsors, and key companies in this region
• Major market participants are partnering with other key stakeholders via signing licensing, commercialization, and development deals to enhance their worldwide business operations
• For instance, in June 2020, uniQure announced a license agreement with CSL Behring for the commercialization of hemophilia B gene therapy

Access Press Release of Gene Therapy Market @ https://www.grandviewresearch.com/press-release/global-gene-therapy-market

Gene Therapy Market Segmentation

Grand View Research has segmented the global gene therapy market on the basis of indication, vector type, and region:

Gene Therapy Indication Outlook (Revenue, USD Million, 2017-2028)

• Acute Lymphoblastic Leukemia (ALL)
• Inherited Retinal Disease
• Large B-cell Lymphoma
• ADA-SCID
• Melanoma (lesions)
• Beta-Thalassemia Major/SCD
• Head & Neck Squamous Cell Carcinoma
• Peripheral Arterial Disease
• Spinal Muscular Atrophy (SMA)
• Others

Gene Therapy Vector Type Outlook (Revenue, USD Million, 2017-2028)

• Lentivirus
• AAV
• Retrovirus & gamma Retrovirus
• Modified Herpes Simplex Virus
• Adenovirus
• Non-viral Plasmid Vector

Gene Therapy Regional Outlook (Revenue, USD Million, 2017-2028)

• North America
  • US.
  • Canada
• Europe
• Asia Pacific
  • Japan
  • China
  • Russia
• Australia
• Rest of the World

List of Key Players of Gene Therapy Market

• REGENXBIO, Inc.
• Oxford BioMedica plc
• Dimension Therapeutics, Inc.
• Bristol-Myers Squibb Company
• SANOFI
• Applied Genetic Technologies Corporation
• Hoffmann-La Roche Ltd.
• Bluebird Bio, Inc.
• Novartis AG
• Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
• UniQure N.V.
• Shire Plc
• Cellectis S.A.
• Sangamo Therapeutics, Inc.
• Orchard Therapeutics
• Gilead Lifesciences, Inc.
• Benitec Biopharma Ltd.
• Sibiono GeneTech Co., Ltd.
• Shanghai Sunway Biotech Co., Ltd.
• Gensight Biologics S.A.
• Transgene
• Calimmune, Inc.
• Epeius Biotechnologies Corp.
• Astellas Pharma, Inc.
• American Gene Technologies
• BioMarin Pharmaceuticals, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wearable Injectors Market Projected to Discern Stable Expansion by 2028

 Wearable Injectors Market Growth & Trends

The global wearable injectors market size is expected to reach USD 18.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.2% from 2021 to 2028. Wearable injectors are drug administration devices designed to deliver drugs in large volumes subcutaneously. It is gaining popularity owing to its advantages such as reduced pain, ease of administration, and elimination of costly health facility visits.

Over the last decade, patient interest in the self-administration of injectable drug therapies has grown. The increasing prevalence of diabetes, chronic pain, and auto-immune diseases, such as rheumatoid arthritis, is increasing the use of wearable injectors. Their demand is increasing for the long-term management of asthma, chronic obstructive pulmonary disease (COPD), high cholesterol, and cancer. This is expected to create a lucrative opportunity for advanced device manufacturers to make wearable devices used to administer larger dose volumes at the comfort of home.

The recent COVID-19 pandemic has brought remote care technologies, such as wearable injectors, into the spotlight. Demand for chronic disease products remains largely unaffected by the pandemic. Since wearable injectors serve with the option of delivering medications at home, its demand has also remained stable or rather grown for the short term. Patients suffering from chronic diseases are opting for these devices as it reduces the risk of exposure to COVID-19 by eliminating hospital visits. The pandemic has, however, affected some of the devices in the pipeline, affecting short-term investments. Leading players who continue to invest in innovation push projects forward despite COVID-19 are expected to put their companies in a stronger competitive position post-crisis.

Request a free sample copy or view report summary: Wearable Injectors Market Report

Wearable Injectors Market Report Highlights

• By type, the on-body segment led the market in 2020 owing to its advantage to be worn on the skin
• The spring-based technology segment held the largest share of 36.3% in 2020 due to a rise in demand for adhesive patches for the treatment of chronic conditions, such as cancer and diabetes
• The home care end-use segment led the market in 2020. This can be attributed to a rise in preference for self-administration, especially during the COVID-19 pandemic
• North America dominated the market with a share of 41.5% in 2020 owing to the rising prevalence of chronic diseases

Access Press Release of Wearable Injectors Market @ https://www.grandviewresearch.com/press-release/global-wearable-injectors-market

Wearable Injectors Market Segmentation

Grand View Research has segmented the global wearable injectors market based on type, technology, application, end-use, and region:

Wearable Injectors Type Outlook (Revenue, USD Million, 2016 - 2028)

• On-body
• Off-body

Wearable Injectors Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Spring-based
• Motor-driven
• Rotary Pump
• Expanding Battery
• Others

Wearable Injectors Application Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Others

Wearable Injectors End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Home Care
• Others

Wearable Injectors Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Wearable Injectors Market

• Becton, Dickinson and Company
• Johnson & Johnson Services, Inc.
• Hoffmann-La Roche Ltd.
• Unilife Corporation
• SteadyMed Therapeutics, Inc.
• Amgen, Inc.
• Insulet Corporation
• Enable Injections
• West Pharmaceutical Services, Inc.
• CeQur SA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Drug Of Abuse Testing Services Market Key Players ,Industry Share ,Growth, And Forecast To 2028: Grand View Research Inc.

 Drug Of Abuse Testing Services Market Growth & Trends

The global drug of abuse testing services market size is expected to reach USD 3.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. The imposition of stringent laws mandating alcohol and illicit substance abuse testing is anticipated to drive the market during the forecast period. However, the violation of privacy rights while drug testing is considered a challenge and impedes the adoption of such testing services.

Workplace substance abuse is on the rise despite random tests being conducted by organizations. Commonly abused illicit drugs on the job are cannabis and cocaine. In the workplace, substance abuse might lead to significant loss of productivity, physical injuries, and even fatalities. On the basis of various drug abuse surveys, around 22.5% of people do not admit using alcohol or any illicit drugs during working hours. Around 1 in 10 respondents say that they come prepared to avoid the risk of random tests at the workplace. Therefore, there is a growing need for rapid and frequent drug of abuse testing at the workplace in order to minimize loss of productivity, absenteeism, and healthcare costs. However, with the COVID-19 crisis and subsequent lockdown scenarios throughout the world, people are staying at and working from home, which is expected to reduce the number of substance abuse cases at the workplace.

The National Institute on Drug Abuse (NIDA) has been established as one of the major federal agencies focused on supporting scientific research on drug use disorders and their consequences, thus improving public health. In March 2020, the NIDA issued a Notice of Special Interest (NOSI) highlighting the urgent need for research and data collection and analysis on the risks of COVID-19 infection in people suffering from substance use disorders. This pandemic is a potential threat to individuals who smoke tobacco or marijuana or try vaping, as the infection affects the lungs. This initiative aims at the submission of applications for Competitive Revisions to active grants, targeting research about SARS-CoV-2 infection risks in individuals with substance use disorders, especially with marijuana, nicotine, methamphetamine, and opioids.

Request a free sample copy or view report summary: Drug Of Abuse Testing Services Market Report

Drug Of Abuse Testing Services Market Report Highlights

• By drug type, cannabis/marijuana accounted for the largest market share in 2020. This can be attributed to the growing usage of cannabis across the world, especially in the U.S.
• The opioids drug type segment held a significant revenue share in 2020 due to the growing cultivation and trading of opioids in Asian countries and a rise in related overdose deaths
• North America accounted for the largest market share in 2020 due to the highest consumption of illicit drugs in the U.S. as well as the imposition of various drug policies mandating drug screening in the country
• Latin America is anticipated to witness the fastest growth during the forecast period owing to the increasing usage and trading of illegal drugs
• COVID-19 has led to a significant rise in alcohol and other substance abuse globally; however, demand for drug testing has declined due to the increased focus on measures to combat the pandemic

Access Press Release of Drug Of Abuse Testing Services Market @ https://www.grandviewresearch.com/press-release/global-drugs-abuse-testing-services-market

Drug Of Abuse Testing Services Market Segmentation

Grand View Research has segmented the global drug of abuse testing services market on the basis of drug type and region:

Drug Of Abuse Testing Services Drug Type Outlook (Revenue, USD Million, 2016 - 2028)

• Alcohol
• Cannabis/Marijuana
• Cocaine
• Opioids
• Amphetamine & Methamphetamine
• LSD
• Others

Drug Of Abuse Testing Services Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
  • Chile
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Drug Of Abuse Testing Services Market

• Quest Diagnostics
• Abbott Laboratories
• Clinical Reference Laboratory (CRL), Inc.
• Laboratory Corporation of America Holdings
• Cordant Health Solutions
• Legacy Medical Services
• DrugScan
• Omega Laboratories, Inc.
• Psychemedics Corporation
• Millennium Health
• Mayo Clinic Laboratories
• Precision Diagnostics
• American Substance Abuse Professionals, (ASAP) Inc.
• United States Drug Testing Laboratories (USDTL), Inc.
• LGC Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Burn Care Market Soaring Demand Assures Motivated Revenue Share By 2028

Burn Care Market Growth & Trends

The global burn care market size is expected to reach USD 3.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.9% from 2021 to 2028. Increasing incidences of burn injuries are anticipated to fuel the demand for cost-effective treatment over the forecast period. As per the WHO, 96.0% of fatal fire-related burns occur in low to middle-income countries. According to the data published by WHO, on average 265,000 deaths are caused by burns every year. The majority of these deaths occur in low to middle-income countries and half of them occur in South East Asia. Moreover, around 1,000,000 people in India are moderately or severely burnt and around 173,000 children in Bangladesh are burnt each year. It also reported that in the U.S., approximately 4,500 burn victims die annually and 10,000 die due to burn-related infections. Owing to this substantial increase in the number of burn incidences, the patient population for burn care and treatment has increased. This in turn is expected to drive market growth over the forecast period.

Furthermore, due to the rising incidences of burn, the demand for treatment options is increasing and as a result, the overall healthcare expenditure on burn care is increasing. Treatment options for burn care include advanced dressings, biologics, traditional burn care products, and others. The foam dressings developed from semipermeable polyurethane are waterproof and can be used on heavily exuding wounds. As a result of which they are preferred over normal dressings which are not waterproof and need to be changed regularly.

Request a free sample copy or view report summary: Burn Care Market Report

Burn Care Market Report Highlights

• The moist wound dressing segment dominated the market in 2020 due to the rising technological advancements and increasing demand for advanced treatment options
• On the basis of depth of wound, the partial thickness burn segment is anticipated to witness the fastest growth over the forecast period. The growth of the segment is attributable to the favorable reimbursement policies in the developed countries
• The hospitals segment accounted for the largest share of the market owing to the increasing incidence of burn injuries and hospitalizations each year
• The thermal burns segment held the largest share of the market in 2020 owing to a high incidence of fire-related burn injuries

Access Press Release of Burn Care Market @ https://www.grandviewresearch.com/press-release/global-burn-care-market

Burn Care Market Segmentation

Grand View Research has segmented the burn care market on the basis of the product, depth of wound, cause, end-use, and region:

Burn Care Product Outlook (Revenue, USD Million, 2016 - 2028)

• Advanced Dressing
  • Alginate Dressing
  • Collagen Dressing
  • Hydrogel Dressing
  • Hydrocolloid Dressings
  • Wound Contact Layers
  • Film Dressings
  • Foam Dressings
  • Others
• Biologics
• Traditional Burn Care Products
• Others

Burn Care Depth of Wound Outlook (Revenue, USD Million, 2016 - 2028)

• Minor Burns
• Partial Thickness Burns
• Full Thickness Burns

Burn Care Cause Outlook (Revenue, USD Million, 2016 - 2028)

• Thermal Burns
• Electrical Burns
• Radiation Burns
• Chemical Burns
• Friction Burns

Burn Care End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Others

Burn Care Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Burn Care Market

• 3M
• Hollister Incorporated
• Cardinal Health
• Integra LifeSciences Corporation
• KCI Licensing, Inc. (Acelity L.P. Inc.)
• Coloplast Corp.
• DeRoyal Industries, Inc.
• Smith & Nephew
• ConvaTec Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Vertical Farming Market is Estimated To Reach A Valuation of $21.15 Billion by 2028: Grand View Research Inc.

 Vertical Farming Market Growth & Trends

The global vertical farming market size is anticipated to reach USD 21.15 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 23.6% over the forecast period. Increased use of Internet of Things (IoT) sensors for producing crops is likely to spur the market demand over the forecast period. Information obtained from the sensors is stored on the cloud and analyzed to perform the required actions. Growing automation in agriculture and increasing use of big data and predictive analytics for maximizing yields are also likely to drive the market.

Vertical farming is effective in ensuring stability in crop production and maintaining reliability even in adverse climatic conditions. It provides multiple benefits over traditional farming techniques, such as less use of water, the lesser need for agrochemicals, and low dependence on agricultural labors. Vertical farming makes use of metal reflectors and artificial lighting to maximize natural sunlight.

Genetically modified organisms and environmental and health effects of pesticides and other non-natural substances that are used for increasing agricultural production have encouraged consumers to adopt organic foods. According to the Organic Trade Association, the U.S. organic industry sales increased by around 5% in 2019, owing to increased investment in infrastructure and education. As per the Organic Foods Production Act of 1990, the handlers and growers of organic products need to comply with the regulations.

Artificial lighting helps in extending the hours of natural daylight, which further increases the health, growth rate, and yield of the plants. Artificial lighting such as high-pressure sodium lighting and LED lighting can extend the availability of crops (throughout a season). LED lighting systems produce a dual-band color spectrum and generate low heat. They are anticipated to witness significant growth over the forecast period.

The hydroponic system is a method of growing plants without soil. A hydroponic system eliminates the need for pesticides and artificial ripening agents and helps in producing nutritionally-rich vegetables. However, factors such as high initial investment and fewer crop varieties are likely to restrain the market growth.

Request a free sample copy or view report summary: Vertical Farming Market Report

Vertical Farming Market Report Highlights

• The escalating production of biopharmaceutical products is anticipated to drive the market
• The building-based segment is expected to portray a high CAGR of 25.9% over the projected period
• The climate control segment is expected to witness a high CAGR over the forecast period, as the growth of crops can be controlled by monitoring and adjusting the concentrations of minerals
• The aeroponics segment is also expected to register considerable growth over the forecast period, as the aeroponics facilitates fast growth in plants (under normal conditions)
• North America is expected to register significant growth over the forecast period, owing to the expansion of small-scale, commercial vertical farms
• The key players of the market include BrightFarms (U.S.), Everlight Electronics Co., Ltd. (Taiwan), and Green Sense Farms, LLC (U.S.)

Vertical Farming Market Segmentation

Grand View Research has segmented the global vertical farming market based on structure; offering; growing mechanism; fruits, vegetables, & herbs; and region:

Vertical Farming Structure Outlook (Revenue, USD Million, 2017 - 2028)

• Shipping Container
• Building-based

Vertical Farming Offering Outlook (Revenue, USD Million, 2017 - 2028)

• Lighting
• Hydroponic Components
• Climate Control
• Sensors

Vertical Farming Growing Mechanism Outlook (Revenue, USD Million, 2017 - 2028)

• Hydroponics
• Aeroponics
• Aquaponics

Vertical Farming Fruits, Vegetables, & Herbs Outlook (Revenue, USD Million, 2017 - 2028)

• Tomato
• Lettuce
• Bell & Chili Peppers
• Strawberry
• Cucumber
• Leafy Greens
• Herbs
• Others

Vertical Farming Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Singapore
  • South Korea
• South America
  • Brazil
• Middle East and Africa (MEA)

List of Key Players in Vertical Farming Market

• AeroFarms
• Freight Farms
• Green Sense Farms, LLC
• BrightFarms Inc.
• Everlight Electronics Co., Ltd.
• Agrilution Systems GmbH

Access Press Release of Vertical Farming Market @ https://www.grandviewresearch.com/press-release/global-vertical-farming-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Corporate Wellness Market Overview and Rising Dependency on Factors 2021 – 2028: Grand View Research Inc.

 

Corporate Wellness Market Growth & Trends

The global corporate wellness market size is expected to reach USD 93.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.0% from 2021 to 2028. Rising obese and overweight population increases insurance costs that account for the financial burden on the employers. The corporate wellness initiatives target particular health risk factors such as stress, obesity, smoking, poor eating, and lack of exercise.

The pandemic has caused a change in the process of delivering wellness services. Although in-person sessions have resumed to some extent, the virtual platform has been made available to at-risk employees to meet their psychological and fitness needs. Initially, the lockdown imposed due to COVID19 resulted in transition to work from home, causing a great deal of stress. 

Employers have started offering some kind of fitness program for the purpose of disease prevention and improve productivity. According to a study conducted by Harvard economists, absenteeism costs fall by USD 2.7 for every dollar spent on fitness programs. Therefore, employees need to be encouraged to adopt a healthier lifestyle to improve their performance.

Employers providing the programs have noticed a significant rise in productivity and a decline in leaves and attrition. In addition, companies in the U.K. initiated the Fit for Work service, which offers a tax benefit of USD 663.3 per year. Organizations are providing wearables, such as Fitbit, Apple watch, and Google watches, which helps in keeping track of parameters such as heart rate and blood pressure.

Access Research Report of Corporate Wellness Market@ https://www.grandviewresearch.com/industry-analysis/corporate-wellness-market

Corporate Wellness Market Report Highlights

• The health risk assessment segment dominated the overall market in terms of revenue share in the year 2020. The health screening activities enable employers to implement strategic initiatives to deal with the identified health risks
• The stress management segment is likely to showcase the fastest growth rate from 2021 to 2028, owing to the rising preference for on-site yoga and meditation services
• Large scale organizations dominated the end use segment in the market in 2020. The infrastructure in large scale companies makes conducting fitness services easier and convenient
• North America dominated the market in terms of revenue share in 2020 due to popularity of corporate wellness in the region. According to a survey by Benefits Canada conducted on 1300 employers, North America had the highest number of corporate wellness programs. In this region, more than 80.0% of the employers are offering corporate wellness services to their employees
• Companies around the globe are modifying their corporate wellness strategies to meet the emerging public health crisis due to COVID 19, though the effect has been surprisingly positive

Access Press Release of Corporate Wellness Market@ https://www.grandviewresearch.com/press-release/global-corporate-wellness-market

Corporate Wellness Market Segmentation

Grand View Research has segmented the global corporate wellness market on the basis of service, end-use, category, delivery model, and region:

Corporate Wellness Service Outlook (Revenue, USD Million, 2016 - 2028)

• Health Risk Assessment
• Fitness
• Smoking Cessation
• Health Screening
• Nutrition & Weight Management
• Stress Management
• Others

Corporate Wellness End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Small Scale Organizations
• Medium Scale Organizations
• Large Scale Organizations

Corporate Wellness Category Outlook (Revenue, USD Million, 2016 - 2028)

• Fitness & Nutrition Consultants
• Psychological Therapists
• Organizations/Employers

Corporate Wellness Delivery Model Outlook (Revenue, USD Million, 2016 - 2028)

• Onsite
• Offsite

Corporate Wellness Regional Outlook(Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa

List of Key Players of Corporate Wellness Market

• Medtronic (Covidien)
• ComPsych
• Wellness Corporate Solutions
• Virgin Pulse
• Provant Health Solutions
• EXOS
• Marino Wellness
• Privia Health
• Vitality Group
• Wellsource, Inc.
• Central Corporate Wellness
• Truworth Wellness
• SOL Wellness

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Patient Engagement Solutions Market Outlook, Leading Manufacturers, Industry Analysis And Forecast: Grand View Research Inc.

 Patient Engagement Solutions Market Growth & Trends

The global patient engagement solutions market size is expected to reach USD 70.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 21.4% from 2021 to 2028. The market is expected to register exponential growth due to the adoption of m-health; increasing prevalence of chronic conditions such as diabetes, asthma, and arthritis; improved healthcare services; enhanced patient education; patient data tracking; and diagnostic treatment.

In January 2021, the Biden-Harris administration opened a “Special Enrollment Period”. Under this action, Americans to sign up for health coverage and roll back attacks on the Medicaid, Affordable Care Act, and access to reproductive health care. Hence, such orders meet the healthcare requirements formed by the COVID-19 outbreak, it will protect access to reproductive health care, and make health care system easier and more unbiassed. Such initiatives are anticipated to drive the demand for these services over the forecast period.

As healthcare providers were battling with the constant upsurge in numerous cases, patients were looking to digital technologies for the support which promoted the adoption of a product. The outbreak has resulted in the introduction of multiple COVID-19- related features patient engagement solutions by various players. The growing number of smartphone users around the globe expedited the adoption of mHealth across the sector both from providers and consumers which in turn, has augmented the dependability of patients on mHealth apps.

Moreover, in March 2019, the American Medical Association entered a collaboration with Patient Point with the aim to access point of care to help prevent the occurrence of cardiovascular diseases and type 2 diabetes. Using Patient Point technology, approximately 6,500 practicing doctors across U.S. are expected to educate individuals regarding disease prevention. Programs such as these are expected to drive market growth over the forecast period.

The necessity of social distancing resulted in the demand for remote patient monitoring solutions along with the prerequisite for the precise and timely exchange of patient wellbeing records. The pandemic has also made healthcare professionals look for alternate methods to traditional processes and systems. As a result, market participants had come up with COVID-19- related features into their existing patient engagement solutions. For instance, in 2020, Orion Health has established the first complete pandemic outbreak monitoring platform to control the spread of the coronavirus. Hence, it led to the adoption of the solutions.

Request a free sample copy or view report summary: Patient Engagement Solutions Market Report

Patient Engagement Solutions Market Report Highlights

• The web-based/cloud-based emerged as the largest delivery type segment in 2020 and accounted for over 80.0% revenue share as it supports hassle-free information flow between patients and healthcare providers. Moreover, bulk data can be stored in these platforms and enable remote access
• The software segment dominated the market in 2020, owing to continuous development in patient engagement solutions along with its increasing applications in consulting, education, and implementation. Software solutions are easy to install and use, enable quick access to specific drug information, and enable healthcare providers to digitally upload prescriptions
• Rising prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes, which require constant monitoring, is expected to drive the demand for these services in the coming years
• The chronic diseases segment dominated the market in 2020 owing to the associated benefits of these solutions in chronic disease management. These solutions help patients connect with their healthcare providers from remote locations, thereby enabling streamlined flow of information, patient feedback, and other health-related data
• North America dominated the market in 2020 owing to increased adoption of m-health and Electronic Health Record (EHR) and growing investments in patient engagement software by major companies
• Companies are adopting various strategies to sustain competition. New product/solution development, partnerships, mergers, acquisitions, strategic collaborations, and geographical penetration are some of the key strategies adopted by market players  

Access Press Release of Patient Engagement Solutions Market@ https://www.grandviewresearch.com/press-release/global-patient-engagement-solutions-market

Patient Engagement Solutions Market Segmentation

Grand View Research has segmented the global patient engagement solutions market based on delivery type, component, end-use, application, therapeutic area, and region:

Patient Engagement Solutions Delivery Type Outlook (Revenue, USD Million, 2016 - 2028)

• Web-based/Cloud-based
• On-premise

Patient Engagement Solutions Component Outlook (Revenue, USD Million, 2016 - 2028)

• Software
  • Standalone
  • Integrated
• Services
  • Consulting
  • Implementation
  • Education
  • Others
• Hardware

Patient Engagement Solutions End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Payers
• Providers
• Individual Users

Patient Engagement Solutions Application Outlook (Revenue, USD Million, 2016 - 2028)

• Social Management
• Health Management
• Home Healthcare Management
• Financial Health Management

Patient Engagement Solutions Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2028)

• Chronic diseases
  • Obesity
  • Diabetes
  • Cardiovascular
  • Others
• Fitness
• Women's Health
• Mental Health
• Others

Patient Engagement Solutions Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Patient Engagement Solutions Market

• Allscripts Healthcare Solutions
• McKesson Corporation
• Orion Health Ltd.
• Cerner Corporation
• Phytel Inc.
• Medecision Inc.
• GetWellNetwork Inc.
• YourCareUniverse Inc.
• Lincor Solutions Ltd.
• Athenahealth, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Animal Health Market Estimated to Experience a Hike in Growth by 2028

 

Animal Health Market Growth & Trends

The global animal health market size is expected to reach USD 74.5 billion by 2028 registering a CAGR of 5.9%, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in veterinary care. For instance, MediLabSecure, a laboratory network project (2014-2021), was initiated to identify emerging viruses and pathogens in 19 countries in the Mediterranean regions. In addition, the emergence of veterinary health information systems, specifically in developed economies, is expected to provide high growth potential in the future.

With the help of these systems, data generated in veterinary clinics can be uploaded on the internet, which can be further shared with other researchers and clinicians. Incorporation of this technology will facilitate real-time analysis for fluctuations in disease prevalence. As a result of the aforementioned factors, it is presumed that there will be a significant improvement in the overall penetration rate of veterinary health products, which is anticipated to fuel market growth.

North America captured the largest share of the global market owing to technological advancements, rising incidence of zoonotic diseases, an increasing number of pet owners, and a wide range of definitive measures adopted by welfare organizations. Asia Pacific is expected to exhibit the fastest CAGR over the forecast years as a result of consistent R&D investments by prominent players and their efforts to commercialize branded and generic therapeutics at competitive prices.

Key market participants employ sustainability strategies, such as expanding product portfolio, to gain a competitive advantage. For instance, in April 2019, Merck acquired Antelliq Corp., operational in the field of digital animal identification, traceability, and monitoring solutions. This acquisition helped the former company improve its veterinary vaccines and pharmaceutical solutions portfolio.

Request a free sample copy or view report summary: Animal Health Market Report

Animal Health Market Report Highlights

• The vaccines product segment is expected to exhibit lucrative growth due to a significant increase in the adoption of pets, which demands long-term health plans
• The companion animal type segment is anticipated to register the fastest CAGR from 2021 to 2028 owing to associated health benefits for humans, such as greater psychological stability and reduced anxiety attacks
• The retail and e-commerce distribution channels accounted for notable shares owing to factors, such as convenience associated with online platforms and an increasing number of retail pharmacies
• Point-of-care is the second-fastest-growing end-use segment. The growth is attributed to an increase in demand for productive animals and growing investments in R&D for novel animal products
• In 2020, North America accounted for the largest share of the global market owing to the presence of established pharmaceutical companies consistently striving for extensive commercialization of their products
• Asia Pacific is anticipated to be the fastest-growing regional market over the forecast years owing to high clinical urgency to curb incidence of zoonotic diseases and management of disease outbreaks, such as swine influenza and Ebola

Access Press Release of Animal Health Market@ https://www.grandviewresearch.com/press-release/global-animal-health-market

Animal Health Market Segmentation

Grand View Research has segmented the global animal health market on the basis of animal type, product, distribution channel, end-use, and region:

Animal Health Type Outlook (Revenue, USD Million, 2016 - 2028)

• Production
  • Poultry
  • Swine
  • Cattle
  • Sheep & Goats
  • Fish
• Companion
  • Dogs
  • Cats
  • Horses
  • Others

Animal Health Product Outlook (Revenue, USD Million, 2016 - 2028)

• Vaccines
  • Live Attenuated Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Others
• Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory
  • Analgesics
  • Others
• Feed Additives
  • Nutritional
  • Medicinal
• Diagnostics
  • Instruments
  • Consumables
• Others

Animal Health Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Retail
• E-commerce
• Veterinary Hospitals & Clinics

Animal Health End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Reference Laboratories
• Point-of-Care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others

Animal Health Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Russia
  • Spain
  • The Netherlands
  • Switzerland
  • Sweden
  • Ireland
  • Poland
• Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Thailand
  • Australia
  • South Korea
  • Philippines
  • Malaysia
  • Singapore
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey
  • Iran
  • United Arab Emirates
  • Israel

List of Key Players of Animal Health Market

• Merck Animal Health
• Ceva Santé Animale
• Vetiquinol S.A.
• Zoetis
• Boehringer Ingelheim GmbH
• Bayer AG
• Elanco
• Nutreco N.V.
• Virbac
• Heska Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Magnetic Resonance Imaging Market to Incur Meteoric Growth During 2021 to 2028: Grand View Research Inc.

 MRI Market Growth & Trends

The global magnetic resonance imaging market size is expected to reach USD 8.5 billion by 2028. The market is expected to expand at a CAGR of 6.0% from 2021 to 2028. The growing prevalence of chronic diseases and increasing demand for early diagnostic techniques are the factors expected to drive the market. In addition, the growing adoption of less invasive procedures is also contributing to the growth of the market. Moreover, the growing number of clinical trials to understand the effectiveness and efficiency of magnetic resonance imaging (MRI) machines in various clinical applications is also expected to boost market growth.

End-users such as research institutes and universities are frequently studying the efficiency of MRI devices with high field strength such as 7T, 10T, and 10.5T. The growing number of research studies will help in unlocking the potential usage and advantages of high field MRI machines for various preclinical as well as clinical applications. Currently, 7T MRI machines are only effective in brain and knee imaging, largely due to the absence of advance coil required for these high field machines. Therefore, the development of advance coils to expand the application of 7T MRI machines is expected to propel market growth during the forecast period.

Key market players are adopting various strategies such as mergers and acquisitions, collaborations, and partnerships to be competitive in the market. Aurora Imaging Technology entered into a distribution agreement with Sumec Group Corporation. Under this distribution agreement, Sumec Corporation will distribute MRI portfolio ofAurora Imaging Technology in China. This, in turn, is helping both the companies in geographical expansion.

Request a free sample copy or view report summary: MRI Market Report

MRI Market Report Highlights

• Adoption of advanced imaging technologies is augmenting the growth of the market
• Open system is anticipated to be the fastest growing segment during the forecast period due to its efficiency to accommodate all size of patients without feeling claustrophobic
• MRI for neurological and brain disorders dominated the market largely due to growing number of neurological conditions and increasing demand for less invasive diagnostic procedure
• The high field segment is expected to experience fastest growth largely due to its efficiency to provide detailed images for diagnosis
• Ambulatory surgical centers are expected to exhibit highest growth rate during the forecast period. Government initiatives to improve primary care is one of the major factor impacting the segment growth
• In 2020, North America dominated the magnetic resonance imaging (MRI) market and accounted for the largest revenue share owing to continuous research and high adoption of advanced techniques in the region
• Asia Pacific is anticipated to witness the fastest growth rate over the forecast period due to growing number of clinical studies in the region for high field MRI machines

Access Press Release of Magnetic Resonance Imaging Market @ https://www.grandviewresearch.com/press-release/global-magnetic-resonance-imaging-market

MRI Market Segmentation

Grand View Research has segmented the global magnetic resonance imaging market based on architecture, field strength, application, end-use, and region:

MRI Architecture Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Closed System
• Open System

MRI Field Strength Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Low Field Strength
• Mid Field Strength
• High Field Strength

MRI Application Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Brain and neurological
  • Low Field Strength
  • Mid Field Strength
  • High Field Strength
• Spine and musculoskeletal
  • Low Field Strength
  • Mid Field Strength
  • High Field Strength
• Vascular
  • Low Field Strength
  • Mid Field Strength
  • High Field Strength
• Abdominal
  • Low Field Strength
  • Mid Field Strength
  • High Field Strength
• Cardiac
  • Low Field Strength
  • Mid Field Strength
  • High Field Strength
• Breast
  • Low Field Strength
  • Mid Field Strength
  • High Field Strength
• Other
  • Low Field Strength
  • Mid Field Strength
  • High Field Strength

MRI End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Imaging Centers
• Ambulatory Surgical Centers
• Others

MRI Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • France
  • Spain
  • Sweden
  • Russia
  • The Netherlands
  • Austria
  • Belgium
  • Denmark
  • Norway
  • Portugal
  • Finland
• Asia Pacific
  • India
  • China
  • Japan
  • Thailand
  • South Korea
  • Singapore
  • Malaysia
  • Philippines
  • Taiwan
  • Indonesia
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar

List of Key Players of Magnetic Resonance Imaging Market

• GE Healthcare
• Hitachi Medical Systems America AG.
• Siemens AG
• Toshiba Corporation
• Aurora Imaging Technologies, Inc.
• Koninklijke Philips N.V.
• Esaote SPA
• Sanrad Medical Systems Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.